Experimental study of cardiac lymph dynamics and edema formation in ischemia/reperfusion injury - With reference to the effect of hyaluronidase

Angiology

Volumn 49, Issue 4, 1998, Pages 299-305

  Yotsumoto, Goichi ^a   Moriyama, Yukinori ^a   Yamaoka, Akihiro ^a   Taira, Akira ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; DOG; HEART ARREST; HEART EDEMA; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HYPOTHERMIA; LYMPHATIC DRAINAGE; NONHUMAN; REPERFUSION INJURY;

EID: 0031898118     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/000331979804900408     Document Type: Article

References (29)

1. Ullal SR, Kluge TH, Kerth WJ, et al: Anatomical studies on lymph drainage of the heart in dogs. Ann Surg 175:305-310, 1972.
2. Gervin CA, Hackell DB, Roe CR: Enzyme content of canine cardiac lymph during acute myocardial infarction. Surg Forum 25:175-176, 1974.
3. Sun SC, Lie JT: Cardiac lymphatic obstruction. Ultrastructure of acute-phase myocardial injury in dogs. Mayo Clin Proc 52:785-792, 1977.
4. Szlavy L, Adams DF, Hollenberg NK, et al: Cardiac lymph and lymphatics in normal and infarcted myocardium. Am Heart J 100:323-331, 1980.
5. Solti F, Nemeth V, Juhasz-Nagy A: Effect of acute cardiac lymph stasis on metabolic coronary adaptation in the dog. Lymphology 18:136-142, 1985.
6. Szlavy L, Koster K, Courten A, et al: Early disappearance of lymphatics draining ischemic myocardium in the dog. Angiology 38:73-84, 1987.
7. Laine GA, Allen SJ: Left ventricular myocardial edema. Lymph flow, interstitial fibrosis, and cardiac function. Circ Res 68:1713-1721, 1991.
8. Taira A, Morishita Y, Arikawa K, et al: Flow velocity of cardiac lymph and contractility of the heart: An experimental study. Ann Thorac Surg 23:230-234, 1977.
9. Taira A, Yamashita M, Arikawa K, et al: Cardiac lymph in electrical ventricular fibrillation: An experimental study. Ann Thorac Surg 27:144-147, 1979.
10. Taira A, Uehara K, Fukuda S, et al: Active drainage of cardiac lymph in relation to reduction in size of myocardial infarction: An experimental study. Angiology 41:1029-1036, 1990.
11. Masuda H, Furuzono K, Kamimura R, et al: Experimental study of cardiac lymph in myocardial stunning. Vasc Surg 27:491-499, 1993.
12. Entman ML, Smith CW: Post-reperfusion inflammation: A model of reaction to injury in cardiovascular disease. Cardiovasc Res 28:1301-1311, 1994.
13. Dreyer WJ, Michael LH, Nguyen T, et al: Kinetics of C5a release in cardiac lymph of dogs experiencing coronary artery ischemia-reperfusion injury. Circ Res 71:1518-1524, 1992.
14. Youker KA, Smith CW, Anderson DC, et al: Neutrophil adherence to isolated adult cardiac myocytes: Induction by cardiac lymph collected during ischemia and reperfusion. J Clin Invest 89:602-609, 1992.
15. Kukielka GL, Smith CW, Manning AM, et al: Induction of interleukin-6 synthesis in the myocardium. Potential role in postreperfusion inflammatory injury. Circulation 92:1866-1875, 1995.
16. Dreyer WJ, Smith CW, Michael LH, et al: Canine neutrophil activation by cardiac lymph obtained during reperfusion of ischemic myocardium. Cire Res 65:1751-1762, 1989.
17. Entman ML, Youker KA, Shoji T, et al: Neutrophil induced oxidative injury of cardiac myocytes: A compartmented system requiring CD11b/CD18-ICAM-1 adherence. J Clin Invest 90:1335-1345, 1992.
18. Swinyard EA, Pathak MA: Locally acting drugs. In: The Pharmacological Basis of Therapeutics, ed. 6., ed. by Gilman AG, Goodman LS, Gilman A. New York: McMillan, 1980, pp 951-963.
19. Szabo G, Magyar S: Effect of hyaluronidase on capillary permeability, lymph flow and passage of dye-labelled protein from plasma to lymph. Nature 182:377-379, 1958.
20. de Oliveira JM, Levy MN: Effect of hyarulonidase upon the water content of ischemic myocardium. Am Heart J 60:106-109, 1960.
21. Rovetto MJ: Effect of hyaluronidase and methyl-prednisolone on myocardial function, glucose metabolism, and coronary flow in isolated ischemic rat heart. Circ Res 41:373-379, 1977.
22. Askenazi J, Hillis LD, Dias PE, et al: The effect of hyaluronidase on coronary blood flow following coronary artery occlusion in the dog. Circ Res 40:566-571, 1977.
23. Kloner RA, Fishbein MC, Maclean D, et al: Effect of hyaluronidase during the early phase of acute myocardial ischemia: An ultrastructural and morphometric analysis. Am J Cardiol 40:43-49, 1977.
24. de Oliveira JM, Carballo R, Zimmerman HA: Intravenous injection of hyaluronidase in acute myocardial infarction: Preliminary report of clinical and experimental observations. Am Heart J 57:712-722, 1959.
25. Maroko PR, Libby P, Bloor CM, et al: Reduction by hyaluronidase of myocardial necrosis following coronary artery occlusion. Circulation 46:430-437, 1972.
26. Maclean D, Fishbein MC, Maroko PR, et al: Hyaluronidase-induced reductions of myocardial infarct size. Science 194:199-200, 1976.
27. Hillis LD, Fishbein MC, Braunwald E, et al: The influence of the time interval between coronary artery occlusion and the administration of hyaluronidase on salvage of ischemic myocardium in dogs. Circ Res 41:26-31, 1977.
28. Wetstein L, Simson MB, Feldman PD, et al: Pharmacological modification of myocardial ischemia. Circulation 66:548-554, 1984.
29. Fischer JH, Jeschkeit S, Klein P: Adding a new principle to hypothermie storage preservation - reduction of edema formation by hyaluronidase. Transplantation 58:748-753, 1994.